239 related articles for article (PubMed ID: 35218467)
21. CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress.
Lerchenmüller C; Rabolli CP; Yeri A; Kitchen R; Salvador AM; Liu LX; Ziegler O; Danielson K; Platt C; Shah R; Damilano F; Kundu P; Riechert E; Katus HA; Saffitz JE; Keshishian H; Carr SA; Bezzerides VJ; Das S; Rosenzweig A
Circ Res; 2020 Aug; 127(5):631-646. PubMed ID: 32418505
[TBL] [Abstract][Full Text] [Related]
22. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
24. Hypertrophy-Reduced Autophagy Causes Cardiac Dysfunction by Directly Impacting Cardiomyocyte Contractility.
Ott C; Jung T; Brix S; John C; Betz IR; Foryst-Ludwig A; Deubel S; Kuebler WM; Grune T; Kintscher U; Grune J
Cells; 2021 Apr; 10(4):. PubMed ID: 33916597
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy.
Jin L; Zhou Y; Han L; Piao J
In Vitro Cell Dev Biol Anim; 2020 Feb; 56(2):112-119. PubMed ID: 31845077
[TBL] [Abstract][Full Text] [Related]
26. In vivo cardiac role of migfilin during experimental pressure overload.
Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
[TBL] [Abstract][Full Text] [Related]
27. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.
Song X; Kusakari Y; Xiao CY; Kinsella SD; Rosenberg MA; Scherrer-Crosbie M; Hara K; Rosenzweig A; Matsui T
Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1256-66. PubMed ID: 20861467
[TBL] [Abstract][Full Text] [Related]
28. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
[TBL] [Abstract][Full Text] [Related]
29. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
[TBL] [Abstract][Full Text] [Related]
30. Cardioprotection of Klotho against myocardial infarction-induced heart failure through inducing autophagy.
Wang K; Li Z; Li Y; Liu X; Sun Y; Hong J; Ding Y; Zheng W; Qian L; Xu D
Mech Ageing Dev; 2022 Oct; 207():111714. PubMed ID: 35931242
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
32. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
[TBL] [Abstract][Full Text] [Related]
33. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
34. C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure.
Appari M; Breitbart A; Brandes F; Szaroszyk M; Froese N; Korf-Klingebiel M; Mohammadi MM; Grund A; Scharf GM; Wang H; Zwadlo C; Fraccarollo D; Schrameck U; Nemer M; Wong GW; Katus HA; Wollert KC; Müller OJ; Bauersachs J; Heineke J
Circ Res; 2017 Jan; 120(1):66-77. PubMed ID: 27821723
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes.
Essick EE; Wilson RM; Pimentel DR; Shimano M; Baid S; Ouchi N; Sam F
PLoS One; 2013; 8(7):e68697. PubMed ID: 23894332
[TBL] [Abstract][Full Text] [Related]
36. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
37. Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice.
Liang Q; Xu H; Liu M; Qian L; Yan J; Yang G; Chen L
J Am Heart Assoc; 2022 Jul; 11(13):e025021. PubMed ID: 35730615
[TBL] [Abstract][Full Text] [Related]
38. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
39. Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy.
Wang B; Shen D; Tang J; Li J; Xiao Y; Chen X; Cao C; Han D; Gao E; Zhao W; Zhang J; Chang J
J Cell Mol Med; 2019 Sep; 23(9):6048-6059. PubMed ID: 31222939
[TBL] [Abstract][Full Text] [Related]
40. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
